
Maharashtra FDA Inspects 2,902 Drug Sites
The story in brief
Maharashtra FDA intensified inspections of drug manufacturing and sales, checking 2,902 sites between June and August 2026. Regulatory actions led to 880 licence holders facing penalties, with 677 licences suspended and 203 cancelled. The FDA also seized illegal goods worth Rs 11.41 crore.